Target intelligence / Profile preview

Panton-Valentine Leukocidin (PVL)

Target
PVL
Molecular classification
Exotoxin, Pore-forming toxin, Bicomponent toxin
01

Overview

Panton-Valentine leukocidin (PVL), also known as LukSF, is a bicomponent, pore-forming cytotoxin produced by certain strains of *Staphylococcus aureus*. It is composed of two protein subunits: LukS-PV and LukF-PV. It functions by forming pores in immune cell membranes, leading primarily to neutrophil lysis—a process central to its pathogenicity. PVL is strongly associated with increased virulence in community-associated methicillin-resistant *S. aureus* (CA-MRSA) and some methicillin-susceptible strains. The primary receptor for PVL on human cells is the C5a receptor (hC5aR).

Other names
LukSF
02

Mechanism of action

Pore formation in immune cell membranes

03

Biological functions

Cell lysisImmune suppressionNeutrophil activationApoptosis induction
04

Disease associations

InfectionSkin and soft tissue infectionsNecrotizing pneumoniaStaphylococcus aureus infections
05

Safety considerations

Severe tissue necrosisHigh mortality rate in necrotizing pneumoniaNeutrophil lysis can compromise host defense

Beyond the preview

Go deeper on Panton-Valentine Leukocidin (PVL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panton-Valentine Leukocidin (PVL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call